{"schema_version":"secwatch.filing_event.v1","accession":"0001818382-25-000122","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.108544+00:00","generated_at":"2026-05-17T15:39:43.884298+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Humacyte Q2 revenue $0.3M; 82 civilian hospitals now eligible to purchase Symvess; July sales exceed H1 total","bullets":["Revenue $0.3M in Q2 (incl $0.1M Symvess sales); $0.8M in H1 2025 vs zero prior year.","82 civilian hospitals eligible to purchase Symvess (up from 5 in May); 13 VAC approvals covering multi-hospital networks.","ECAT approval makes Symvess available to ~35 Military Treatment Facilities and ~160 VA hospitals; first military sale in July followed by re-order.","Implemented workforce reduction of 30 employees; expects net savings ~$13.8M in 2025 and ~$38M in 2026.","Cash, cash equivalents, restricted cash $88.4M as of June 30; net cash used $6.9M in H1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001818382-25-000122","json":"https://secwatch.observer/filing/0001818382-25-000122.json","markdown":"https://secwatch.observer/filing/0001818382-25-000122.md","text":"https://secwatch.observer/filing/0001818382-25-000122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000122/0001818382-25-000122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000122/huma-20250811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:39:43.884298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}